|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
PACTR |
|
Last refreshed on:
|
29 April 2013 |
|
Main ID: |
PACTR201105000299318 |
|
Date of registration:
|
16/05/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Using mobile-phone based text messages to improve retention of patients initiating antiretroviral therapy in South Africa
|
|
Scientific title:
|
Using mobile-phone based text messages to improve retention of patients initiating antiretroviral therapy in South Africa |
|
Date of first enrolment:
|
2011-06-01 |
|
Target sample size:
|
1200 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201105000299318 |
|
Study type:
|
interventional |
|
Study design:
|
Parallel: different groups receive different interventions at same time during study,
Randomised,
Permuted block randomisation ,
Allocation will be determined by software package - system allocated patients to intervention arm,
|
|
|
Countries of recruitment
|
|
South Africa
| | | | | | | |
|
Contacts
|
|
Name:
|
Leya
Hassanally |
|
Address:
|
1st Floor CPUT BARC Building Cnr Brandweer/Waterloo St
8001
Cape Town
South Africa |
|
Telephone:
|
27 (0)21 469-1111 |
|
Email:
|
Leya@cell-life.org |
|
Affiliation:
|
Lead Researcher and Co-Principal Investigator |
|
|
Name:
|
Sarah
Brown |
|
Address:
|
1st Floor CPUT BARC Building Cnr Brandweer/Waterloo St
8001
Cape Town
South Africa |
|
Telephone:
|
27 (0)21 469-1111 |
|
Email:
|
Sarah@cell-life.org |
|
Affiliation:
|
Project Manager and Co-Principal Investigator |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients who are 18 years of age or older.
Patients who are initiating ART.
Patients who own or have access to a mobile phone with functional text message features.
Patients who can receive text messages.
Patients who can read text messages.
Patients who agree to continue their ART at the site at which they were initiated for 12 months. In other words, the patient will not be down referred to a local community clinic during the study.
Exclusion criteria: Patients who reside in an area where there is no mobile network reception.
Patients who plan to relocate away from the area or transfer to another antiretroviral treatment facility during the next 12 months.
Patients who are enrolled in other concurrent research studies designed to investigate the effect of mobile-phone based text message reminders to improve retention in treatment.
Patients who belong to a household within which another individual has already enrolled for the study.
Age minimum:
18 Year
Age maximum:
100 Year
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
HIV/AIDS
null
|
|
Primary Outcome(s)
|
|
Retention
|
|
Treatment Interruptions
|
|
Secondary Outcome(s)
|
|
awareness of possible adverse effects and toxicity
|
|
Clinical outcome: HIV-1 RNA viral load and CD4 T-lymphocyte count
|
|
commitment to treatment
|
|
disclosure of HIV status
|
|
experienced stigma and depression
|
|
interpersonal relationships
|
|
knowledge of difficulties experienced during ART initiation
|
|
lifestyle changes for improved health outcomes
|
|
optimistic self-beliefs about health benefits of ART
|
|
patient medication self-efficacy
|
|
perceived social support
|
|
Source(s) of Monetary Support
|
|
Canadian International Development Agency (CIDA)
|
|